Short answer · Medically reviewed summary · Last updated: 2026-04-07
Johanson-Blizzard syndrome is a rare, autosomal recessive genetic disorder characterized by exocrine pancreatic insufficiency, nasal wing aplasia, and developmental delays. While it is officially recognized as Johanson-Blizzard syndrome in modern medical literature, it is occasionally referred to as "nasal-alar hypoplasia-pancreatic insufficiency syndrome" or historically as "JBS" in clinical shorthand. What are the official and common names for Johanson-Blizzard syndrome? In modern clinical practice, Johanson-Blizzard syndrome is the universally accepted terminology.
Johanson-Blizzard syndrome is a rare, autosomal recessive genetic disorder characterized by exocrine pancreatic insufficiency, nasal wing aplasia, and developmental delays. While it is officially recognized as Johanson-Blizzard syndrome in modern medical literature, it is occasionally referred to as "nasal-alar hypoplasia-pancreatic insufficiency syndrome" or historically as "JBS" in clinical shorthand.
In modern clinical practice, Johanson-Blizzard syndrome is the universally accepted terminology. This name honors the physicians who first described the condition in 1971. In medical classification systems, it is indexed under specific codes to ensure consistency: it is identified as ORPHA:472 in the Orphanet database, and it is documented in the Online Mendelian Inheritance in Man (OMIM) database as #243800. While some older medical records or international journals may use descriptive terms, Johanson-Blizzard syndrome remains the standard for diagnosis and research.
The variation in terminology for Johanson-Blizzard syndrome stems from the medical tradition of naming rare diseases after the clinicians who first identified them (eponyms) versus descriptive nomenclature. Historically, when a syndrome was first observed, it was often described by its most prominent physical features. For example, you may encounter the following terms in older literature:
Over time, as the genetic basis—specifically mutations in the UBR1 gene—became understood, the medical community moved toward the eponymous name Johanson-Blizzard syndrome to provide a precise, unified label that avoids the ambiguity of purely descriptive titles.
Medical nomenclature for Johanson-Blizzard syndrome is remarkably consistent globally, largely due to the efforts of the NIH Genetic and Rare Diseases (GARD) Information Center and Orphanet. Regardless of the language, most international medical systems now utilize the standardized English name. If you are reviewing medical records from outside the U.S. or Europe, you might see the condition referred to by the same eponymous name, sometimes followed by the specific UBR1 gene mutation details, which helps clinicians verify the diagnosis across borders.
It is common for patients or caregivers to feel confused when seeing different names for the same diagnosis in medical reports. If your records use terms like "nasal-alar hypoplasia," know that this is simply a clinical descriptor of one of the hallmark features of Johanson-Blizzard syndrome. When communicating with specialists, using the term Johanson-Blizzard syndrome is the most effective way to ensure that your medical team is referencing the correct, evidence-based diagnostic criteria.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.